Companies: 11,396     total market cap: S$190.470 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$NZD๐Ÿ‡ณ๐Ÿ‡ฟ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ
Anavex Life Sciences
AVXL
#9707
Rank
S$0.13 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
S$1.46
Share price
-4.20%
Change (1 day)
-85.52%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech๐Ÿงฌ Genomics
Categories

EPS for Anavex Life Sciences (AVXL)

EPS in 2026 (TTM): S-$0.19

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is S-$0.19. In 2025 the company made an earnings per share (EPS) of S-$0.59.

EPS history for Anavex Life Sciences from 2025 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$0.19-67.31%
2025S-$0.59

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
S$12.81-6,773.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
S$0.67-446.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
S-$9.66 4,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
S-$1.84 860.00%๐Ÿ‡บ๐Ÿ‡ธ USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com